| Institution: | 1. Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada;2. Boehringer Ingelheim Canada Ltd, Burlington, Ontario, Canada;3. Dallas Diabetes Research Center at Medical City, Dallas, Texas, United States;4. Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida, United States;5. Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, United States;6. Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany;7. Metrum Research Group, Tariffville, Connecticut, United States;8. Boehringer Ingelheim International GmbH, Ingelheim, Germany |
